Immuneering (IMRX) Asset Utilization Ratio (2021 - 2023)

Immuneering (IMRX) posted quarterly Asset Utilization Ratio of 0.0 for Q3 2023, down 99.9% year-over-year from 0.0 in Q3 2022, and down 98.86% quarter-over-quarter from 0.0 in Q2 2023.

Immuneering (IMRX) Asset Utilization Ratio (2021 - 2023) Analysis & Trends

Immuneering's Asset Utilization Ratio history runs 3 years deep, the most recent figure standing at 0.0 for Q3 2023.

  • In Q3 2023, Asset Utilization Ratio fell 99.9% year-over-year to 0.0; the TTM figure through Sep 2023 stood at 0.0 (down 99.9% YoY), while the FY2022 annual figure was 0.0, down 89.19% from the prior year.
  • Asset Utilization Ratio for Q3 2023 stood at 0.0, down from 0.0 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.02 in Q3 2021, with the low at 0.0 in Q3 2023.
  • The 3-year median for Asset Utilization Ratio is 0.0 (2022), against an average of 0.01.
  • The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio tumbled 80.32% in 2022, then sank 99.9% in 2023.
  • Immuneering's Asset Utilization Ratio stood at 0.01 in 2021, then sank by 80.32% to 0.0 in 2022, then sank by 99.85% to 0.0 in 2023.
  • Business Quant data shows IMRX's Asset Utilization Ratio at 0.0 in Q3 2023, 0.0 in Q2 2023, and 0.0 in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 0.47
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.38
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.69
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 186.67
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.13
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 0.90
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 0.54
10 Immuneering 327.37 Mn 327.37 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2023 0.00
Jun 30, 2023 0.00
Mar 31, 2023 0.00
Dec 31, 2022 0.00
Sep 30, 2022 0.00
Jun 30, 2022 0.01
Mar 31, 2022 0.01
Dec 31, 2021 0.01
Sep 30, 2021 0.02